Back

Remnant cholesterol and residual ischemic risk after percutaneous coronary intervention: a 10-year real-world cohort study

28 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Percutaneous coronary intervention: risk factors for recurrent events and treatment of calcified and challenging lesions Percutaneous Coronary Intervention (PCI) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ying Song

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

6 More presentations in this session

Presentation thumbnail
Coronary microvascular dysfunction and short-term outcomes after PCI for severely calcified lesions: a comparison between intravascular lithotripsy and rotational atherectomy
Doctor H. Kusumoto (Takatsuki, JP)
Abstract Slides
Presentation thumbnail
Drug-coated balloon versus drug-eluting stent after atherectomy in severely calcified coronary lesions including calcified nodules
Doctor H. Mori (Yokohama, JP)
Abstract Slides
Presentation thumbnail
Contemporary use and outcomes of temporary mechanical circulatory support in patients undergoing percutaneous coronary intervention
Mr O. Emilsson (Lund, SE)
Abstract Slides
Presentation thumbnail
Gender matters more for safety than survival after PCI in elderly patients
Professor A. Lukito (Tangerang, ID)
Abstract Slides
Presentation thumbnail
Predictive value of combined Triglyceride glucose index and stress hyperglycemia ratio for adverse prognosis in elderly patients with coronary artery disease after percutaneous coronary intervention
Miss A. Wang (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Percutaneous coronary intervention: risk factors for recurrent events and treatment of calcified and challenging lesions

The Event

Event poster

ESC Congress 2026

28 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Remnant cholesterol and its role in patients with coronary atherosclerosis evaluated by coronary CT
13 December 2025
thumbnail
Congress Presentation
Long-term follow-up after percutaneous coronary interventions for chronic total occlusions.
1 September 2025
thumbnail
Congress Presentation
PCSK9 inhibitors and cardiovascular outcomes in AMI-BIRISK patients: a multicenter retrospective study
1 September 2025
thumbnail
Congress Presentation
Prognostic significance of elevated lipoprotein(a) in long-term outcomes after PCI with drug-eluting stents
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources